Ovarian cancer

From WikiCover

Ovarian cancer is the second leading gynecologic cancer and, the most deadly, accounting for more than 15,000 deaths annually. Because there is no accurate screening test to detect ovarian cancer, it is typically diagnosed at a late stage when it is more difficult to treat.

Eva Longoria has been named the lead ambassador for a new public service campaign, created in partnership between the Callaway Golf Foundation and the Entertainment Industry Foundation, aimed at raising awareness and funds for ovarian cancer prevention.

In her role as the campaign ambassador, Longoria will appear in both television and print public service announcements to encourage women to better understand their risks for the disease and to urge them to get involved in the cause.

"I was shocked to learn that ovarian cancer is the most deadly reproductive cancer with no early detection test available," said Longoria. "Until there is an early detection test, we are urging all women to get involved in understanding their personal risk for the disease."

Through a $1 million donation to EIF's Women's Cancer Programs, the Callaway Golf Foundation Women's Cancer Initiative has been established at four outstanding cancer institutions to fast-track breakthrough treatments and tests to improve ovarian cancer outcomes. Donations to the Callaway Golf Foundation Women's Cancer Initiative will also benefit the Gynecologic Cancer Foundation. The institutions selected for their groundbreaking work in ovarian cancer research and treatment include: Cedars-Sinai Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute; The University of Texas M.D. Anderson Cancer Center; Memorial Sloan-Kettering Cancer Center; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Led by Dr. Beth Karlan, Director of the Cedars-Sinai Women's Cancer Research Institute, this women's cancer initiative represents a collaborative, multi-site undertaking designed to advance treatment of ovarian cancer through molecular profiling, biomarker discovery and targeted therapy development.

The Callaway Golf Foundation will also host a professional/celebrity golf tournament, the Callaway Golf Foundation Challenge, at the Riviera County Club in Los Angeles, California in November 2007. Proceeds from the tournament will benefit EIF's cancer research programs.